Overexpression of AMPKα2 can enhance the signaling of pink/parkin pathway by phosphorylation, enhance mitophagy, promote the elimination of damaged mitochondria, improve mitochondrial function, reduce ROS production and cardiomyocyte apoptosis, and thereby prevent the early progress of heart failure. Here, PRKAA2 is linked to heart failure.